New discovery advances optical microscopy
Enables researchers to directly visualize unlabeled objects that have deep sub-wavelength separations
Credit: Lynford Goddard, Grainger Engineering
URBANA, Ill. – New Illinois ECE research is advancing the field...
Eclipse data illuminate mysteries of Sun’s corona
Credit: Solar Wind Sherpas
Researchers at the University of Hawai?i Institute for Astronomy (IfA) have been hard at work studying the solar corona, the outermost atmosphere of...
Impact of COVID-19 on the Life Science Industry
/* custom css */
.td_uid_1_5edb04838b318_rand { min-height: 0; }
jQuery(window).load(function () { jQuery('body').find('#td_uid_1_5edb04838b312 .td-element-style').each(function (index, element) { jQuery(element).css('opacity', 1); return; }); }); jQuery(window).ready(function () { // We need timeout because the...
Memo Therapeutics
Candidate: COVID-19 immunotherapy
Category: ANTIBODY
Type: SARS-CoV-2-specific virus-neutralizing antibody, to be selected.
Status: Memo said June 4 that it had identified “several” SARS-CoV-2-specific virus-neutralizing antibodies with the potential for development as a COVID-19 immunotherapy. The “ultra-rare” antibodies...
iBio – IBIO-201
Candidate: IBIO-201
Category: VAX
Type: Subunit vaccine combining antigens derived from the SARS-CoV-2 spike protein fused with the company’s patented lichenase booster molecule (LicKM), designed to enhance immune response.
Status: iBio said June 4 that it has...
Upsized Nasdaq IPO Yields Calliditas €80M to Commercialize Kidney Drug
Swedish company Calliditas Therapeutics has raised an €80M IPO on the Nasdaq Global Select Market — 20% above its initial target — to fund an ongoing phase III trial of its lead candidate treatment...
Researchers investigate new approaches to treating neurodegenerative diseases
Heidelberg researchers investigate new approaches to treating neurodegenerative diseases
Protecting nerve cells from losing their characteristic extensions, the dendrites, can reduce brain damage after a stroke. Neurobiologists from Heidelberg University have demonstrated this by means...
Israeli-Dutch Biotech Raises €55M to Fight Huntington’s Disease and ALS
Prilenia Therapeutics has raised €55M in Series A funding to launch late-stage clinical trials of its small molecule candidate drug in Huntington’s disease and amyotrophic lateral sclerosis, incurable conditions that have very limited treatment...
Farmers in Paraguay see major yield increases with GMO corn, despite degraded soil –...
The GLP Needs Your Help
It is easier than ever for advocacy groups to spread disinformation on pressing science issues, such as the ongoing coronavirus pandemic. No, vaccines are not harmful. Yes, the use of...
Study may pave for new therapeutic approaches for Parkinson’s disease
Researchers have uncovered a link between the structure of the protein alpha-synuclein and its likelihood to misfold and aggregate.
Alpha-synuclein aggregates are the hallmark of neurodegenerative disorders, such as Parkinson's disease. Their findings, published today...
